In Situ Forming Gel with LNG

Product Overview

Development Status: Inactive

Target: Female

Mode: Hormonal

Delivery Type: Injectable

Duration Type: Long-acting

Description: Researchers at the University of Tennessee Health Science Center are developing an in situ forming gel that can achieve 6 months of controlled delivery of LNG.

Updated date: May 30, 2018

Vertical Tabs

Status

Project Phase: Early Development

Project Stage: Pre-clinical

Began discovery in: 2013

Download Product Report